PreveCeutical Medical (FRA:18H0) Total Assets: €0.90 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PreveCeutical Medical Total Assets?

PreveCeutical Medical FRA:18H0 Total Assets is €0.90 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

PreveCeutical Medical's Total Assets for the quarter that ended in Dec. 2025 was €0.90 Mil.

During the past 12 months, PreveCeutical Medical's average Total Assets Growth Rate was 761.70% per year. During the past 3 years, the average Total Assets Growth Rate was 98.90% per year. During the past 5 years, the average Total Assets Growth Rate was 40.30% per year. During the past 10 years, the average Total Assets Growth Rate was 5.50% per year.

During the past 11 years, PreveCeutical Medical's highest 3-Year average Total Assets Growth Rate was 226.10%. The lowest was -61.20%. And the median was 6.10%.

Total Assets is connected with ROA %. PreveCeutical Medical's annualized ROA % for the quarter that ended in Dec. 2025 was 498.47%. Total Assets is also linked to Revenue through Asset Turnover. PreveCeutical Medical's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

PreveCeutical Medical  (FRA:18H0) Total Assets Explanation

Total Assets is connected with ROA %.

PreveCeutical Medical's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=2.936/( (0.281+0.897)/ 2 )
=2.936/0.589
=498.47 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PreveCeutical Medical's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (0.281+0.897)/ 2 )
=0/0.589
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PreveCeutical Medical Total Assets Related Terms

PreveCeutical Medical Total Assets Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Total Assets Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.13 0.12 0.15 0.90

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.17 0.23 0.28 0.90

PreveCeutical Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PreveCeutical Medical's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-3.866+4.762
=0.90

PreveCeutical Medical's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-3.866+4.762
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €0.90 Mil mean?
PreveCeutical Medical (FRA:18H0) has a Total Assets of €0.90 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on PreveCeutical Medical and its competitors.
Is PreveCeutical Medical's Total Assets too high?
PreveCeutical Medical's current Total Assets is €0.90 Mil.
How does PreveCeutical Medical's Total Assets compare to VRTX and REGN?
PreveCeutical Medical's Total Assets of €0.90 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current Total Assets is €0.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current Total Assets of €0.90 Mil. The current Total Assets is €0.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current Total Assets is €0.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges PRVCF:USAPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.